title: [Intrauterine misoprostol for the prevention of bleeding cesarean].
abstract: OBJECTIVE
  To evaluate efficacy of misoprostol by intrauterine route for the prevention of the obstetrical hemorrhage and to know its effects collaterals.
  
  
  METHODS
  Clinical and randomized test with 200 patients to those who one took place to them Caesarean. The Group A was applied placebo and the group B misoprostol (group B; 800 microg) intrauterine, after the birth of its newborns. The necessity of additional uterotonics was compared, loss of hemoglobin and hematocrit, and the effects collaterals.
  
  
  RESULTS
  In group B it diminished the necessity of additional uterotonics to 50% and the loss of hemoglobin in 39.6%. In the group greater loss of 3 was registered g of hemoglobin in 13 versus 3% of the patients. With respect to the hematocrit, its loss was reduced in 40.6%. The patients in those who the hematocrit in more fell than 10%, registered themselves in 7 versus 1% cases. The effects collaterals were few and not so serious.
  
  
  CONCLUSIONS
  The intrauterine combination of misoprostol and oxitocin diminishes the postcaesarean sanguineous loss and has brings about few effects collaterals.
authors.affiliation: Hospital de Ginecología y Obstetricia de Monterrey.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Quiroga Díaz
authors.forename: Reynaldo
authors.initials: R
authors.lastname: Cantú Mata
authors.forename: Héctor E
authors.initials: HE
authors.lastname: Tello Gutiérrez
authors.forename: Mireya
authors.initials: M
authors.lastname: Puente Villalobos
authors.forename: Rogelio
authors.initials: R
authors.lastname: Montemayor Garza
authors.forename: Araceli
authors.initials: A
authors.lastname: Martínez Mendoza
mesh_terms: D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage*; D010120:Oxytocics / Q000008:administration & dosage*; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006473:Postpartum Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D011247:Pregnancy; D014599:Uterus
chemical_list: D010120:Oxytocics; D016595:Misoprostol